AUDRA HOLEMAN: Open Payments
NPI 1235512195 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 22 payments from 13 companies in 2025. Trend: 2023 $159 · 2024 $1,363 · 2025 $2,607
Food & beverage: $2,607
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $374 |
| Teva Pharmaceuticals USA, Inc. | 3 | $373 |
| ACADIA Pharmaceuticals Inc | 3 | $339 |
| ABIOMED | 3 | $286 |
| Boston Scientific Corporation | 2 | $285 |
| Amgen Inc. | 1 | $168 |
| Abbott Laboratories | 1 | $136 |
| Alkermes, Inc. | 1 | $130 |
| Phathom Pharmaceuticals, Inc. | 1 | $121 |
| KYOWA KIRIN, INC. | 1 | $121 |
Products named: Auvelity, AUSTEDO XR, NUPLAZID, TEPEZZA, AMS 700, WATCHMAN FLX, FREESTYLE LIBRE 3, LYBALVI.
Industry payments across IN — which companies pay providers there.
